|
|
|
市場調查報告書
骨質缺乏症:全球臨床實驗回顧(2011年下半年)
Osteopenia Global Clinical Trials Review, H2 2011
| 出版商 |
GlobalData |
| 出版日期 |
2011年10月 |
商品編碼 |
217849 |
| 內容資訊 |
英文 Pages: 105 |
| 價格 |
|
|
骨質缺乏症:全球臨床實驗回顧(2011年下半年) 是由出版商GlobalData在2011年10月所出版的。
這份英文市場調查報告書包含Pages: 105 價格從美金1000起跳。
本報告提供全球各國骨質缺乏症的臨床實驗的相關調查,各地區·進展·階段·募集狀況的實施數量,代表性的贊助商,正在開發的治療藥物資訊,在各企業·機關的進展,彙整以上種種資訊,為您概述為以下內容。
目錄
簡介
骨質缺乏症 本報告內容架構
不同地區的臨床實驗數量
- 各國臨床實驗數量
- 亞太地區前幾名國家
- 歐洲的前幾名國家
- 北美前幾名國家
- 中東·非洲的前幾名國家
- 中南美的前幾名國家
金磚四國的臨床實驗數量
G7各國的臨床實驗數量
E7各國的臨床實驗數量
不同階段臨床實驗數量
各進展狀況臨床實驗數量
尚未完成的臨床實驗數量
一定期間內採用的實驗人數數
著名的贊助商
著名的治療藥物比較
臨床實驗簡介
- 前幾名企業臨床實驗概況
- Amgen Inc.
- Novartis AG
- Warner Chilcott Plc
- Medtronic Spine LLC
- POM Wonderful, LLC
- BioActor
- Emisphere Technologies, Inc.
- Bayer AG
- Teva Pharmaceutical Industries Limited
- Pfizer Inc.
- 小野藥品工業
- Nestle SA
- Marina Biotech, Inc.
- Merck & Co., Inc.
- GlaxoSmithKline plc
- Sanofi
- Abbott Laboratories
- F. Hoffmann-La Roche Ltd.
- Johnson & Johnson
- 前幾名大學·研究機關·醫院臨床實驗概況
- University of Wisconsin Madison
- Massachusetts General Hospital
- Hospices Civils de Lyon
- University of Sao Paulo
- University of Erlangen-Nurnberg
- The National Institute of Allergy and Infectious Diseases
- Seoul National University Hospital
- 神戶大學
- Columbia University
- McGill University Health Center
- Bayside Health
- University of Missouri
- Medical University of Vienna
- Emory University
- Queen's University
- University of New Mexico
- Purdue University
- U.S. Department of Veterans Affairs
- Washington University School of Medicine
- University of California, San Francisco
5個有代表性的臨床實驗簡介
附錄
圖表一覽
Abstract
Summary
GlobalData's clinical trial report, "Osteopenia Global Clinical Trials Review, H2, 2011" provides data on the Osteopenia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Osteopenia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Osteopenia. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table of Contents
- Table of Contents
- List of Tables
- List of Figures
- Introduction
- Osteopenia
- Report Guidance
- Clinical Trials by Region
- Clinical Trials by Country
- Top Five Countries Contributing to Clinical Trials in Asia-Pacific
- Top Five Countries Contributing to Clinical Trials in Europe
- Top Countries Contributing to Clinical Trials in North America
- Top Countries Contributing to Clinical Trials in Middle East and Africa
- Top Countries Contributing to Clinical Trials in Central and South America
- Clinical Trials by BRIC Nations
- Clinical Trials by G7 Nations
- Clinical Trials in G7 Nations by Trial Status
- Clinical Trials by E7 Nations
- Clinical Trials in E7 Nations by Trial Status
- Clinical Trials by Phase
- In Progress Trials by Phase
- Clinical Trials by Trial Status
- Unaccomplished Trials of Osteopenia
- Subjects Recruited Over a Period of Time
- Prominent Sponsors
- Top Companies Participating in Osteopenia Therapeutics Clinical Trials
- Prominent Drug Comparison
- Clinical Trial Profiles
- Clinical Trial Overview of Top Companies
- Amgen Inc.
- Clinical Trial Overview of Amgen Inc.
- Novartis AG
- Clinical Trial Overview of Novartis AG
- Warner Chilcott Plc
- Clinical Trial Overview of Warner Chilcott Plc
- Medtronic Spine LLC
- Clinical Trial Overview of Medtronic Spine LLC
- POM Wonderful, LLC.
- Clinical Trial Overview of POM Wonderful, LLC.
- BioActor
- Clinical Trial Overview of BioActor
- Emisphere Technologies, Inc.
- Clinical Trial Overview of Emisphere Technologies, Inc.
- Bayer AG
- Clinical Trial Overview of Bayer AG
- Teva Pharmaceutical Industries Limited
- Clinical Trial Overview of Teva Pharmaceutical Industries Limited
- Pfizer Inc.
- Clinical Trial Overview of Pfizer Inc.
- Ono Pharmaceutical Co., Ltd.
- Clinical Trial Overview of Ono Pharmaceutical Co., Ltd.
- Nestle SA
- Clinical Trial Overview of Nestle SA
- Marina Biotech, Inc.
- Clinical Trial Overview of Marina Biotech, Inc.
- Merck & Co., Inc.
- Clinical Trial Overview of Merck & Co., Inc.
- GlaxoSmithKline plc
- Clinical Trial Overview of GlaxoSmithKline plc
- Sanofi
- Clinical Trial Overview of Sanofi
- Abbott Laboratories
- Clinical Trial Overview of Abbott Laboratories
- F. Hoffmann-La Roche Ltd.
- Clinical Trial Overview of F. Hoffmann-La Roche Ltd.
- Johnson & Johnson
- Clinical Trial Overview of Johnson & Johnson
- Clinical Trial Overview of Top Universities / Institutes / Hospitals
- University of Wisconsin Madison
- Clinical Trial Overview of University of Wisconsin Madison
- Massachusetts General Hospital
- Clinical Trial Overview of Massachusetts General Hospital
- Hospices Civils de Lyon
- Clinical Trial Overview of Hospices Civils de Lyon
- University of Sao Paulo
- Clinical Trial Overview of University of Sao Paulo
- University of Erlangen-Nurnberg
- Clinical Trial Overview of University of Erlangen-Nurnberg
- The National Institute of Allergy and Infectious Diseases
- Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases
- Seoul National University Hospital
- Clinical Trial Overview of Seoul National University Hospital
- Kobe University
- Clinical Trial Overview of Kobe University
- Columbia University
- Clinical Trial Overview of Columbia University
- McGill University Health Center
- Clinical Trial Overview of McGill University Health Center
- Bayside Health
- Clinical Trial Overview of Bayside Health
- University of Missouri
- Clinical Trial Overview of University of Missouri
- Medical University of Vienna
- Clinical Trial Overview of Medical University of Vienna
- Emory University
- Clinical Trial Overview of Emory University
- Queen's University
- Clinical Trial Overview of Queen's University
- University of New Mexico
- Clinical Trial Overview of University of New Mexico
- Purdue University
- Clinical Trial Overview of Purdue University
- U.S. Department of Veterans Affairs
- Clinical Trial Overview of U.S. Department of Veterans Affairs
- Washington University School of Medicine
- Clinical Trial Overview of Washington University School of Medicine
- University of California, San Francisco
- Clinical Trial Overview of University of California, San Francisco
- Five Key Clinical Profiles
Appendix
- Abbreviations
- Definitions
- Research Methodology
- Secondary Research
- About GlobalData
- Contact Us
- Disclaimer
- Source
List of Tables
- Osteopenia Therapeutics Market, Global, Clinical Trials by Zone, 2011*
- Osteopenia Therapeutics Market, Global, Clinical Trials by Top Countries, 2011*
- Osteopenia Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2011*
- Osteopenia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2011*
- Osteopenia Therapeutics Clinical Trials, Europe, Top Five Countries, 2011*
- Osteopenia Therapeutics Clinical Trials, North America, Top Countries, 2011*
- Osteopenia Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2011*
- Osteopenia Therapeutics Clinical Trials, Central and South America, Top Countries, 2011*
- Osteopenia Therapeutics Clinical Trials, BRIC Countries, 2011*
- Osteopenia Therapeutics Clinical Trials, G7 Countries, 2011*
- Osteopenia Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2011*
- Osteopenia Therapeutics Clinical Trials, E7 Countries, 2011*
- Osteopenia Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2011*
- Osteopenia Therapeutics Market, Global, Clinical Trials by Phase, 2011*
- Osteopenia Therapeutics Market, Global, Clinical Trials In Progress by Phase 2011*
- Osteopenia Therapeutics Market, Global, Clinical Trials by Trial Status, 2011*
- Osteopenia Therapeutics Market, Global, Withdrawn Clinical Trials, 2011*
- Osteopenia Therapeutics Market, Global, Terminated Clinical Trials, 2011*
- Osteopenia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010
- Osteopenia Therapeutics Clinical Trials, Global, Key Sponsors, 2011*
- Osteopenia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2011*
- Osteopenia Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2011*
- Osteopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Amgen Inc., 2011*
- Osteopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2011*
- Osteopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Warner Chilcott Plc, 2011*
- Osteopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Medtronic Spine LLC, 2011*
- Osteopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by POM Wonderful, LLC., 2011*
- Osteopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by BioActor, 2011*
- Osteopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Emisphere Technologies, Inc., 2011*
- Osteopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2011*
- Osteopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Teva Pharmaceutical Industries Limited, 2011*
- Osteopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2011*
- Osteopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Ono Pharmaceutical Co., Ltd., 2011*
- Osteopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Nestle SA, 2011*
- Osteopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Marina Biotech, Inc., 2011*
- Osteopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2011*
- Osteopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2011*
- Osteopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2011*
- Osteopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Abbott Laboratories, 2011*
- Osteopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2011*
- Osteopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2011*
- Osteopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Wisconsin Madison, 2011*
- Osteopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2011*
- Osteopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Hospices Civils de Lyon, 2011*
- Osteopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Sao Paulo, 2011*
- Osteopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Erlangen-Nurnberg, 2011*
- Osteopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Allergy and Infectious Diseases, 2011*
- Osteopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Seoul National University Hospital, 2011*
- Osteopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Kobe University, 2011*
- Osteopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Columbia University, 2011*
- Osteopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by McGill University Health Center, 2011*
- Osteopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayside Health, 2011*
- Osteopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Missouri, 2011*
- Osteopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical University of Vienna, 2011*
- Osteopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Emory University, 2011*
- Osteopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Queen's University, 2011*
- Osteopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of New Mexico, 2011*
- Osteopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Purdue University, 2011*
- Osteopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by U.S. Department of Veterans Affairs, 2011*
- Osteopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Washington University School of Medicine, 2011*
- Osteopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Francisco, 2011*
List of Figures
- Osteopenia Therapeutics Market, Global, Clinical Trials by Zone (%), 2011*
- Osteopenia Therapeutics Market, Global, Clinical Trials by Top Countries, 2011*
- Osteopenia Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2011*
- Osteopenia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2011*
- Osteopenia Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2011*
- Osteopenia Therapeutics Clinical Trials, North America, Top Countries (%), 2011*
- Osteopenia Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2011*
- Osteopenia Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2011*
- Osteopenia Therapeutics Clinical Trials, BRIC Countries (%), 2011*
- Osteopenia Therapeutics Clinical Trials, G7 Countries (%), 2011*
- Osteopenia Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2011*
- Osteopenia Therapeutics Clinical Trials, E7 Countries (%), 2011*
- Osteopenia Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2011*
- Osteopenia Therapeutics Market, Global, Clinical Trials by Phase (%), 2011*
- Osteopenia Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2011*
- Osteopenia Therapeutics Market, Global, Clinical Trials by Trial Status, 2011*
- Osteopenia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010
- Osteopenia Therapeutics Clinical Trials, Global, Key Sponsors, 2011*
- Osteopenia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2011*
- Osteopenia Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2011*
- GlobalData Methodology
|

|